Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    24066742 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
Conditions: Thrombocytopenia;   Platelet Transfusion Refractoriness
Intervention:
2 Withdrawn Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation
Condition: Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
Intervention: Drug: Eculizumab

Study has passed its completion date and status has not been verified in more than two years.